Physician profile
Daniel S Sandusky
NPI 1902241136
$2,671.90
in general payments reported to CMS, 2019-2025
9 companies · $28.25 in 2025
The $28.25 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,661 · 2020: $304 · 2022: $63.52 · 2023: $538 · 2024: $76.51 · 2025: $28.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,467.32 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $475.69 | 2019-2020 | |
| Spr Therapeutics, INC | $316.82 | 2023 | Sprint Pns System |
| Nevro Corp. | $209.63 | 2019-2022 | |
| Vertos Medical, INC. | $59.55 | 2023 | Mild Device Kit |
| Heron Therapeutics, INC. | $46.49 | 2024 | Aponvie |
| Biotronik Nro, INC. | $38.70 | 2023 | Biotronik |
| Medtronic, INC. | $30.02 | 2024 | Intellis Adaptivestim |
| Stryker Corporation | $27.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sandusky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.